Reviva Pharmaceuticals (RVPH) Earnings Date, Estimates & Call Transcripts $0.78 -0.01 (-0.76%) Closing price 03:58 PM EasternExtended Trading$0.79 +0.01 (+1.02%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Reviva Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Mar. 31) -$0.22 Actual EPS (Mar. 31) -$0.15 Beat By $0.07 Reviva Pharmaceuticals posted Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.15, which beat analysts' consensus estimates of -$0.22 by $0.07. With a trailing EPS of -$0.91, Reviva Pharmaceuticals' earnings are expected to grow next year, from ($0.97) to ($0.79) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)RVPH Upcoming EarningsReviva Pharmaceuticals' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Reviva Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Reviva Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRVPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Reviva Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.24-$0.24-$0.24Q2 20251-$0.23-$0.23-$0.23Q3 20251-$0.21-$0.21-$0.21Q4 20251-$0.16-$0.16-$0.16 FY 2025 4 -$0.84 -$0.84 -$0.84 Q1 20261-$0.16-$0.16-$0.16Q2 20261-$0.16-$0.16-$0.16Q3 20261-$0.17-$0.17-$0.17Q4 20261-$0.19-$0.19-$0.19 Reviva Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/31/2025Q4 2024-$0.22-$0.15+$0.07-$0.15--8/14/2024--$0.28-$0.26+$0.02-$0.26--5/14/2024Q4 2023-$0.28-$0.25+$0.03-$0.25--4/15/2024Q4 2023--$0.35 -$0.35-$0.35--11/14/2023Q3 2023-$0.35-$0.44 -$0.09-$0.44--8/14/2023Q2 2023-$0.29-$0.55 -$0.26-$0.55--5/15/2023Q1 2023-$0.36-$0.30+$0.06-$0.30-- Reviva Pharmaceuticals Earnings - Frequently Asked Questions When is Reviva Pharmaceuticals's earnings date? Reviva Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on RVPH's earnings history. Did Reviva Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Reviva Pharmaceuticals (NASDAQ:RVPH) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.07. Learn more on analysts' earnings estimate vs. RVPH's actual earnings. How much profit does Reviva Pharmaceuticals generate each year? Reviva Pharmaceuticals (NASDAQ:RVPH) has a recorded net income of -$39.26 million. RVPH has generated -$0.91 earnings per share over the last four quarters. What is Reviva Pharmaceuticals's EPS forecast for next year? Reviva Pharmaceuticals's earnings are expected to grow from ($0.97) per share to ($0.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies DERM Earnings IKT Earnings TNGX Earnings PBYI Earnings LFVN Earnings LXEO Earnings FTLF Earnings EPRX Earnings VIGL Earnings NKTX Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Disney Stock Jumps on Earnings—Is the Magic Sustainable?Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? This page (NASDAQ:RVPH) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersThe New ElonThe New Face of DOGE? There is now a new, powerful and controversial figure at the heart of the DOGE agenda...Altimetry | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVPH Stock Free RVPH Stock Alerts